phase ii trial of xpro1595 for the treatment of alzheimer’s disease
Published 1 year ago • 202 plays • Length 9:17Download video MP4
Download video MP3
Similar videos
-
2:35
inmune bio phase 2 clinical trial of xpro in alzheimer's disease
-
3:39
inflammation in alzheimer’s disease and the potential of gm-csf treatment
-
54:42
webinar on xpro1595 phase ib interim data of neuroinflammation in patients with alzheimer's disease
-
59:38
clinical trials, fad variants, and the etiology of alzheimer’s disease
-
10:28
emerging treatments for early alzheimer’s disease: mechanisms of action
-
0:46
uncovering the reality of end-stage alzheimer's: how the dying process unfolds 😶🌫
-
7:04
alzheimer's disease - first symptoms, progression and prognosis
-
1:40
the prodromal phases of alzheimer’s disease
-
36:55
therapeutic advances in the early treatment of alzheimer’s disease
-
3:01
geoff kerchner, md, phd: phase iii trials of crenezumab in treatment of prodromal to mild alzheimer
-
29:54
presymptomatic treatment for alzheimer's disease: feasible or fanciful? (15 nov 2012)
-
35:03
early treatment of alzheimer’s disease
-
46:16
alzheimer’s disease: the latest updates on diagnosis and treatment - geoffrey kerchner, md, phd
-
1:44
how xpro1595 ("xpro") is unique to other tnf inhibitors
-
1:05:11
advances in the treatment of alzheimer’s disease: preparing for a shift in the treatment paradigm
-
44:42
presymptomatic treatment for the dementias: plausibility and perils
-
31:24
plenary 2: from biomarkers to precision medicine in alzheimer's disease
-
1:00:16
individualized clinical mgt. of patients at risk for alzheimer's dementia - richard isaacson, md
-
9:04
positive results from an alzheimer's clinical trial